Literature DB >> 21148238

Cerebellar-dependent eyeblink conditioning deficits in schizophrenia spectrum disorders.

Jennifer K Forsyth1, Amanda R Bolbecker, Crystal S Mehta, Mallory J Klaunig, Joseph E Steinmetz, Brian F O'Donnell, William P Hetrick.   

Abstract

Accumulating evidence suggests that abnormalities in neural circuitry and timing associated with the cerebellum may play a role in the pathophysiology of schizophrenia. Schizotypal personality disorder (SPD) may be genetically linked to schizophrenia, but individuals with SPD are freer from potential research confounds and may therefore offer insight into psychophysiological correlates of schizophrenia. The present study employed a delay eyeblink conditioning (EBC) procedure to examine cerebellar-dependent learning in schizophrenia, SPD, and healthy control subjects (n = 18 per group) who were matched for age and gender. The conditioned stimulus was a 400-ms tone that coterminated with a 50 ms unconditioned stimulus air puff. Cognitive performance on the Picture Completion, Digit Symbol Coding, Similarities, and Digit Span subscales of the Wechsler Adult Intelligence Scale--Third Edition was also investigated. The schizophrenia and SPD groups demonstrated robust EBC impairment relative to the control subjects; they had significantly fewer conditioned responses (CRs), as well as smaller CR amplitudes. Schizophrenia subjects showed cognitive impairment across subscales compared with SPD and control subjects; SPD subjects showed intermediate performance to schizophrenia and control subjects and performed significantly worse than controls on Picture Completion. Impaired EBC was significantly related to decreased processing speed in schizophrenia spectrum subjects. These findings support the role of altered cortico-cerebellar-thalamic-cortical circuitry in the pathophysiology of schizophrenia spectrum disorders.

Entities:  

Mesh:

Year:  2010        PMID: 21148238      PMCID: PMC3406528          DOI: 10.1093/schbul/sbq148

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  63 in total

1.  A PET study of the pathophysiology of negative symptoms in schizophrenia. Positron emission tomography.

Authors:  Steven G Potkin; Gustavo Alva; Kirsten Fleming; Ravi Anand; David Keator; Danilo Carreon; Michael Doo; Yi Jin; Joseph C Wu; James H Fallon
Journal:  Am J Psychiatry       Date:  2002-02       Impact factor: 18.112

2.  Increased expression of activity-dependent genes in cerebellar glutamatergic neurons of patients with schizophrenia.

Authors:  Rodrigo D Paz; Nancy C Andreasen; Sami Z Daoud; Robert Conley; Rosalinda Roberts; Juan Bustillo; Nora I Perrone-Bizzozero
Journal:  Am J Psychiatry       Date:  2006-10       Impact factor: 18.112

3.  Reduced volume of the cerebellar vermis in neuroleptic-naive schizophrenia.

Authors:  T Ichimiya; Y Okubo; T Suhara; Y Sudo
Journal:  Biol Psychiatry       Date:  2001-01-01       Impact factor: 13.382

4.  Eyelid conditioning and arousal in schizophrenic and normal subjects.

Authors:  B Spain
Journal:  J Abnorm Psychol       Date:  1966-08

5.  Childhood motor coordination and adult schizophrenia spectrum disorders.

Authors:  Jason Schiffman; Holger J Sorensen; Justin Maeda; Erik L Mortensen; Jeff Victoroff; Kentaro Hayashi; Niels M Michelsen; Morten Ekstrom; Sarnoff Mednick
Journal:  Am J Psychiatry       Date:  2009-07-15       Impact factor: 18.112

Review 6.  Relationship of schizotypal personality disorder to schizophrenia: genetics.

Authors:  S Torgersen
Journal:  Schizophr Bull       Date:  1985       Impact factor: 9.306

7.  Cerebellar pathology in schizophrenia: a controlled postmortem study.

Authors:  D R Weinberger; J E Kleinman; D J Luchins; L B Bigelow; R J Wyatt
Journal:  Am J Psychiatry       Date:  1980-03       Impact factor: 18.112

8.  Working memory span and motor and cognitive speed in schizophrenia.

Authors:  Gildas Brébion; Anthony S David; Hugh M Jones; Lyn S Pilowsky
Journal:  Cogn Behav Neurol       Date:  2009-06       Impact factor: 1.600

9.  Cerebellum volume and eyeblink conditioning in schizophrenia.

Authors:  Chad R Edwards; Sharlene Newman; Andrew Bismark; Patrick D Skosnik; Brian F O'Donnell; Anantha Shekhar; Joseph E Steinmetz; William P Hetrick
Journal:  Psychiatry Res       Date:  2008-01-28       Impact factor: 3.222

10.  Cerebellar blood flow in schizophrenic patients and normal control subjects.

Authors:  J L Steinberg; M D Devous; F G Moeller; R G Paulman; J D Raese; R R Gregory
Journal:  Psychiatry Res       Date:  1995-05-31       Impact factor: 3.222

View more
  28 in total

Review 1.  Consensus paper: roles of the cerebellum in motor control--the diversity of ideas on cerebellar involvement in movement.

Authors:  Mario Manto; James M Bower; Adriana Bastos Conforto; José M Delgado-García; Suzete Nascimento Farias da Guarda; Marcus Gerwig; Christophe Habas; Nobuhiro Hagura; Richard B Ivry; Peter Mariën; Marco Molinari; Eiichi Naito; Dennis A Nowak; Nordeyn Oulad Ben Taib; Denis Pelisson; Claudia D Tesche; Caroline Tilikete; Dagmar Timmann
Journal:  Cerebellum       Date:  2012-06       Impact factor: 3.847

2.  Cerebellar volume and cerebellocerebral structural covariance in schizophrenia: a multisite mega-analysis of 983 patients and 1349 healthy controls.

Authors:  T Moberget; N T Doan; D Alnæs; T Kaufmann; A Córdova-Palomera; T V Lagerberg; J Diedrichsen; E Schwarz; M Zink; S Eisenacher; P Kirsch; E G Jönsson; H Fatouros-Bergman; L Flyckt; G Pergola; T Quarto; A Bertolino; D Barch; A Meyer-Lindenberg; I Agartz; O A Andreassen; L T Westlye
Journal:  Mol Psychiatry       Date:  2017-05-16       Impact factor: 15.992

3.  Consensus paper: Decoding the Contributions of the Cerebellum as a Time Machine. From Neurons to Clinical Applications.

Authors:  Martin Bareš; Richard Apps; Laura Avanzino; Assaf Breska; Egidio D'Angelo; Pavel Filip; Marcus Gerwig; Richard B Ivry; Charlotte L Lawrenson; Elan D Louis; Nicholas A Lusk; Mario Manto; Warren H Meck; Hiroshi Mitoma; Elijah A Petter
Journal:  Cerebellum       Date:  2019-04       Impact factor: 3.847

4.  Disrupted modular architecture of cerebellum in schizophrenia: a graph theoretic analysis.

Authors:  Dae-Jin Kim; Jerillyn S Kent; Amanda R Bolbecker; Olaf Sporns; Hu Cheng; Sharlene D Newman; Aina Puce; Brian F O'Donnell; William P Hetrick
Journal:  Schizophr Bull       Date:  2014-04-29       Impact factor: 9.306

5.  Cerebellar-thalamic connectivity in schizophrenia.

Authors:  Deanna M Barch
Journal:  Schizophr Bull       Date:  2014-06-03       Impact factor: 9.306

6.  Mistiming of thought and perception predicts delusionality.

Authors:  Adam Bear; Rebecca G Fortgang; Michael V Bronstein; Tyrone D Cannon
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-18       Impact factor: 11.205

7.  Polarity- and Intensity-Independent Modulation of Timing During Delay Eyeblink Conditioning Using Cerebellar Transcranial Direct Current Stimulation.

Authors:  Jessica Mitroi; Leah P Burroughs; Alexandra B Moussa-Tooks; Amanda R Bolbecker; Nancy B Lundin; Brian F O'Donnell; William P Hetrick
Journal:  Cerebellum       Date:  2020-06       Impact factor: 3.847

8.  Impaired cerebellar-dependent eyeblink conditioning in first-degree relatives of individuals with schizophrenia.

Authors:  Amanda R Bolbecker; Jerillyn S Kent; Isaac T Petersen; Mallory J Klaunig; Jennifer K Forsyth; Josselyn M Howell; Daniel R Westfall; Brian F O'Donnell; William P Hetrick
Journal:  Schizophr Bull       Date:  2013-08-20       Impact factor: 9.306

9.  A magnetic resonance imaging-safe method for the study of human eyeblink conditioning.

Authors:  Jerillyn S Kent; D Michael Bailey; Jennifer M Vollmer; Sharlene D Newman; Amanda R Bolbecker; Brian F O'Donnell; William P Hetrick
Journal:  J Neurosci Methods       Date:  2013-03-13       Impact factor: 2.390

10.  Postural Sway Abnormalities in Schizotypal Personality Disorder.

Authors:  Deborah Apthorp; Amanda R Bolbecker; Lisa A Bartolomeo; Brian F O'Donnell; William P Hetrick
Journal:  Schizophr Bull       Date:  2019-04-25       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.